Cerreta F - Search Results

1

Regulatory considerations on the enrollment of older adults in oncology clinical trials.

Raimi-Abraham BT, de Orbe Izquierdo MS, Collignon O, Cerreta F. Raimi-Abraham BT, et al. Among authors: cerreta f. J Geriatr Oncol. 2017 May;8(3):151-153. doi: 10.1016/j.jgo.2017.02.006. Epub 2017 Mar 9. J Geriatr Oncol. 2017. PMID: 28284754 No abstract available.

2

Regulatory activities to address the needs of older patients.

Cerreta F, Temple R, Asahina Y, Connaire C. Cerreta F, et al. J Nutr Health Aging. 2015 Feb;19(2):232-3. doi: 10.1007/s12603-014-0494-4. J Nutr Health Aging. 2015. PMID: 25651451 Free article.

3

Medicines for older people: assessment and transparency at the European Medicines Agency regarding cardiovascular and antithrombotic medicinal products.

Cerreta F, Padrão A, Skibicka-Stepien I, Strampelli A, de Orbe Izquierdo MS. Cerreta F, et al. Eur Geriatr Med. 2018 Aug;9(4):415-418. doi: 10.1007/s41999-018-0071-1. Epub 2018 Jun 14. Eur Geriatr Med. 2018. PMID: 34674494

4

Drug policy for an aging population--the European Medicines Agency's geriatric medicines strategy.

Cerreta F, Eichler HG, Rasi G. Cerreta F, et al. N Engl J Med. 2012 Nov 22;367(21):1972-4. doi: 10.1056/NEJMp1209034. N Engl J Med. 2012. PMID: 23171092 No abstract available.

5

Medication use among older people in Europe: Implications for regulatory assessment and co-prescription of new medicines.

Strampelli A, Cerreta F, Vučić K. Strampelli A, et al. Among authors: cerreta f. Br J Clin Pharmacol. 2020 Oct;86(10):1912-1920. doi: 10.1111/bcp.14462. Epub 2020 Jul 26. Br J Clin Pharmacol. 2020. PMID: 32644249 Free PMC article.

6

Regulatory incentives to ensure better medicines for older people: From ICH E7 to the EMA reflection paper on quality aspects.

van Riet-Nales DA, Hussain N, Sundberg KA, Eggenschwyler D, Ferris C, Robert JL, Cerreta F. van Riet-Nales DA, et al. Among authors: cerreta f. Int J Pharm. 2016 Oct 30;512(2):343-351. doi: 10.1016/j.ijpharm.2016.05.001. Epub 2016 May 2. Int J Pharm. 2016. PMID: 27150947 Free article. Review.

7

Baseline Frailty Evaluation in Drug Development.

Cerreta F, Ankri J, Bowen D, Cherubini A, Cruz Jentoft AJ, Guðmundsson A, Haberkamp M, Jansen P, Marchionni N, Morgan S, Rönnemaa E, Petrovic M, Pilotto A, Rosa M, Wildiers H. Cerreta F, et al. J Frailty Aging. 2016;5(3):139-40. doi: 10.14283/jfa.2016.99. J Frailty Aging. 2016. PMID: 27554312 No abstract available.

8

New harmonized considerations on the evaluation instruments for baseline characterization of frailty in the European Union.

Cerreta F; European Medicines Agency Geriatric Expert Group. Cerreta F, et al. Br J Clin Pharmacol. 2019 Jul 5;86(10):2017-9. doi: 10.1111/bcp.14044. Online ahead of print. Br J Clin Pharmacol. 2019. PMID: 31276597 Free PMC article. No abstract available.

9

Medicines Adaptive Pathways to Patients: Why, When, and How to Engage?

Eichler HG, Bedlington N, Boudes M, Bouvy JC, Broekmans AW, Cerreta F, Faulkner SD, Forda SR, Joos A, Le Cam Y, Mayer MH, Pirard V, Corriol-Rohou S; ADAPT SMART Consortium. Eichler HG, et al. Among authors: cerreta f. Clin Pharmacol Ther. 2019 May;105(5):1148-1155. doi: 10.1002/cpt.1121. Epub 2018 Sep 11. Clin Pharmacol Ther. 2019. PMID: 29901216 Free PMC article. Review.

10

The evolution of adaptiveness: balancing speed and evidence.

Eichler HG, Barker R, Bedlington N, Bouvy JC, Broekmans AW, Bucsics A, Cerreta F, Corriol-Rohou S, Granados A, Le Cam Y, Schuurman A. Eichler HG, et al. Among authors: cerreta f. Nat Rev Drug Discov. 2018 Dec;17(12):845-846. doi: 10.1038/nrd.2018.90. Epub 2018 Jul 6. Nat Rev Drug Discov. 2018. PMID: 29977052 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

28 results

Search Page

Filters